--2025/Q4-- / 359.056M--
--2025/Q3-- / 353.944M--
Nov 7, 20242025/Q2345.511M / 342.578M--
Aug 8, 20242025/Q1336.172M / 335.040M--
May 9, 20242024/Q4343.290M / 329.468M--
US Stock MarketDetailed Quotes
HAE Haemonetics
- 86.300
- +1.380+1.63%
Trading Nov 21 11:43 ET
4.33BMarket Cap35.81P/E (TTM)
86.660High84.420Low254.03KVolume84.900Open84.920Pre Close21.76MTurnover0.51%Turnover Ratio37.69P/E (Static)50.22MShares97.97052wk High4.93P/B4.29BFloat Cap70.25052wk Low--Dividend TTM49.72MShs Float142.110Historical High--Div YieldTTM2.64%Amplitude6.344Historical Low85.669Avg Price1Lot Size
Haemonetics Key Stats
Haemonetics Q2 2025 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 342.58M | 345.51M | +2.93M |
| Beat Est. | +7.67% | +8.59% | +0.86% |
| EPS | 0.77 | 0.66 | -0.11 |
| Miss Est. | +60.00% | +37.50% | -14.06% |
Analyst Rating
Nov 21, 2024
Haemonetics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Haemonetics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data